文献速递肝病

胶原 proportionate area 是非酒精性脂肪性肝病患者长期结局的独立预测因素

Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease.
PubMed 文献 · Aliment Pharmacol Ther · 2019-03-18

研究在三个欧洲中心连续纳入437例活检证实的非酒精性脂肪性肝病患者,评估胶原 proportionate area(CPA)量化纤维化及预测临床结局的能力,中位随访103个月。CPA与肝硬度及纤维化分期相关,高倍CPA在F0-F3期显著高于标准CPA,但在肝硬化期相似。基线年龄、高倍CPA和晚期纤维化是肝脏相关临床结局的独立预测因素。

要点

  • CPA与肝硬度及纤维化分期在全纤维化谱系中相关。
  • 高倍CPA在F0-F3期显著高于标准CPA,肝硬化期相似。
  • 基线年龄、高倍CPA和晚期纤维化为肝脏相关结局的独立预测因素。

核心结论

  • CPA准确测量纤维化,是非酒精性脂肪性肝病临床结局的独立预测因素,因此值得在临床试验中作为替代终点进一步评估。

研究设计与样本

  • 研究评估来自三个欧洲中心的连续活检证实的非酒精性脂肪性肝病患者,收集基线与末次临床随访或死亡时的临床和实验室数据。
  • CPA在两种客观放大倍数下进行:全活检宏观和×4物镜放大,分别命名为标准放大(SM)和高倍放大(HM)。
  • 在部分患者亚组中评估CPA与肝硬度之间的相关性。

主要发现

  • 437例患者中,32例(7.3%)在中位随访103个月期间发生失代偿和/或死于肝脏相关原因。
  • CPA与肝硬度及肝纤维化分期在整个纤维化谱系中相关。
  • HM CPA在F0-F3期显著高于SM CPA,但在肝硬化期相似,反映早期阶段捕获细胞周围/窦周纤维化的能力更高。
  • 基线年龄(HR:1.04,95%CI:1.01-1.08)、HM CPA(每增加1%,HR:1.04,95%CI:1.01-1.08)和晚期纤维化(HR:15.4,95%CI:5.02-47.84)在标准和竞争风险多变量Cox回归分析中是肝脏相关临床结局的独立预测因素。

关键数值与推荐

  • CPA与肝硬度及肝纤维化分期在整个纤维化谱系中相关。
  • HM CPA在F0-F3期显著高于SM CPA,但在肝硬化期相似。
  • 基线年龄(HR:1.04,95%CI:1.01-1.08)、HM CPA(每增加1%,HR:1.04,95%CI:1.01-1.08)和晚期纤维化(HR:15.4,95%CI:5.02-47.84)为肝脏相关临床结局的独立预测因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Collagen proportionate area (CPA) measurement is a technique that quantifies fibrous tissue in liver biopsies by measuring the amount of collagen deposition as a proportion of the total biopsy area. CPA predicts clinical outcomes in patients with HCV and can sub-classify cirrhosis. AIM: To test the ability of CPA to quantify fibrosis and predict clinical outcomes in patients with NAFLD. METHODS: We assessed consecutive patients with biopsy-proven NAFLD from three European centres. Clinical and laboratory data were collected at baseline and at the time of the last clinical follow-up or death. CPA was performed at two different objective magnifications, whole biopsy macro and ×4 objective magnification, named standard (SM) and high (HM) magnification respectively. The correlation between CPA and liver stiffness was assessed in a sub-group of patients. RESULTS: Of 437 patients, 32 (7.3%) decompensated and/or died from liver-related causes during a median follow-up of 103 months. CPA correlated with liver stiffness and liver fibrosis stage across the whole spectrum of fibrosis. HM CPA was significantly higher than SM CPA in stages F0-F3 but similar in cirrhosis, reflecting a higher ability to capture pericellular/perisinusoidal fibrosis at early stages. Age at baseline (HR: 1.04, 95% CI: 1.01-1.08), HM CPA (HR: 1.04 per 1% increase, 95% CI: 1.01-1.08) and presence of advanced fibrosis (HR: 15.4, 95% CI: 5.02-47.84) were independent predictors of liver-related clinical outcomes at standard and competing risk multivariate Cox-regression analysis. CONCLUSIONS: CPA accurately measures fibrosis and is an independent predictor of clinical outcomes in NAFLD; hence it merits further evaluation as a surrogate endpoint in clinical trials.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Buzzetti E, Hall A, Ekstedt M, et al. Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2019. PMID: 30882933. doi:10.1111/apt.15219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。